Maxi Nicotine

Generic: nicotine polacrilex

Labeler: Rite Aid Corporation
NDC Directory HUMAN OTC DRUG ANDA Inactive

Drug Facts

Product Profile

Brand Name Maxi Nicotine
Generic Name nicotine polacrilex
Labeler Rite Aid Corporation
Dosage Form LOZENGE
Routes
ORAL
Active Ingredients

NICOTINE 4 mg/1

Identifiers & Regulatory

Product NDC 11822-3319
Product ID 11822-3319_49f0cabc-dbb7-4a76-a882-871b1fd1e240
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA210712
Marketing Start 2021-07-09
Marketing End 2026-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 118223319
Hyphenated Format 11822-3319

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Maxi Nicotine (source: ndc)
Generic Name nicotine polacrilex (source: ndc)
Application Number ANDA210712 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 3 BOTTLE, PLASTIC in 1 BOX (11822-3319-0) / 24 LOZENGE in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

11822-3319-0 3 BOTTLE, PLASTIC in 1 BOX (11822-3319-0) / 24 LOZENGE in 1 BOTTLE, PLASTIC

Ingredients (1)

NICOTINE (4 mg/1)

Linked Drug Pages (1)

Maxi Nicotine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "49f0cabc-dbb7-4a76-a882-871b1fd1e240", "openfda": {"nui": ["N0000175706", "M0014836"], "upc": ["0011822331500"], "unii": ["6M3C89ZY6R"], "rxcui": ["359818"], "spl_set_id": ["5674ba36-8b62-4e46-81e5-ef2c57bea102"], "pharm_class_cs": ["Nicotine [CS]"], "pharm_class_epc": ["Cholinergic Nicotinic Agonist [EPC]"], "manufacturer_name": ["Rite Aid Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BOTTLE, PLASTIC in 1 BOX (11822-3319-0)  / 24 LOZENGE in 1 BOTTLE, PLASTIC", "package_ndc": "11822-3319-0", "marketing_end_date": "20260228", "marketing_start_date": "20210709"}], "brand_name": "Maxi Nicotine", "product_id": "11822-3319_49f0cabc-dbb7-4a76-a882-871b1fd1e240", "dosage_form": "LOZENGE", "pharm_class": ["Cholinergic Nicotinic Agonist [EPC]", "Nicotine [CS]"], "product_ndc": "11822-3319", "generic_name": "nicotine polacrilex", "labeler_name": "Rite Aid Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Maxi Nicotine", "active_ingredients": [{"name": "NICOTINE", "strength": "4 mg/1"}], "application_number": "ANDA210712", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20210709"}